Bajolo, Allan A.
HRN: 23-52-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/19/2023
08/25/2023
IV
1.5g
Q6
Soft Tissue Infection; Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes